News Briefs Calyxo inks $32.7m Series C to remove kidney stones Questa Capital and CRG led the round. Iris Dorbian - 6 July 2022 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in